Analytical Data
-
Gene name
C9orf106
- Application
-
Alternative Names
C9orf106Putative uncharacterized Protein C9orf106
-
Species
Human
-
Source
E. coli
-
Tag
GST-tag at N-terminal
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q8NAJ2
-
Expression Region
1-232aa
-
AA Sequence
MAYVALSDKPHLSGEVGEEACSSWNPPLFSPRPLPRLWPLPGTPFLPIRALPFSASSSGKSSLVPSPSSSAHSGFRTPCLGPDCLLCTQGCELHEGRNHMAVHSCVARAWPGDPQEVRHLNPLLCDPGSQVEPSWPWHPGLEQAAASWVGNHVSPAHRQALRGHSLGSALRALMPGRHCPLCVPCKRGCNLRGGRGKHGPRPCCPLLRKFPVLPVHPWPFPCAVWDSGWSCR
-
Molecular Weight
25.6 KDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
C9orf106, a gene located on chromosome 9, has recently attracted attention due to its potential role in various biological processes and its association with neurological disorders. Research has indicated that mutations in C9orf106 may be linked to the pathogenesis of Alzheimer's disease and amyotrophic lateral sclerosis (ALS), highlighting its significance in neurodegenerative conditions. The protein encoded by C9orf106 is believed to be involved in cellular stress responses and possibly modulating inflammation in the brain. Given its emerging profile, the production of recombinant C9orf106 protein allows for further investigation into its structure, function, and interactions at the molecular level. Such studies can uncover how protein alterations contribute to disease mechanisms and may lead to novel therapeutic strategies. The exploration of C9orf106's biological properties and its implications in health and disease is crucial for understanding its role in neurobiology and developing potential interventions for associated disorders.
